However, its clinical utility should be carefully assessed in comparison with other established biomarkers, such as anti-Müllerian hormone (AMH), LH/FSH ratio, and androgen levels, which are currently utilized in PCOS diagnosis and classification [31,32]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.